The UB creates the Chair on Innovation in Precision Oncology
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumour1
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumour1
The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZene1
Reserachers of Hospital Clínic-IDIBAPS participate in EuCanImage, a project from the Horizon 2020 program that will build a federated and scalable ca1
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the co1
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining th1